Literature DB >> 15322195

Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.

Klaus Ruckdeschel1, Gudrun Pfaffinger, Rudolf Haase, Andreas Sing, Heike Weighardt, Georg Häcker, Bernhard Holzmann, Jürgen Heesemann.   

Abstract

TLRs are important sensors of the innate immune system that serve to identify conserved microbial components to mount a protective immune response. They furthermore control the survival of the challenged cell by governing the induction of pro- and antiapoptotic signaling pathways. Pathogenic Yersinia spp. uncouple the balance of life and death signals in infected macrophages, which compels the macrophage to undergo apoptosis. The initiation of apoptosis by Yersinia infection specifically involves TLR4 signaling, although Yersinia can activate TLR2 and TLR4. In this study we characterized the roles of downstream TLR adapter proteins in the induction of TLR-responsive apoptosis. Experiments using murine macrophages defective for MyD88 or Toll/IL-1R domain-containing adapter inducing IFN-beta (TRIF) revealed that deficiency of TRIF, but not of MyD88, provides protection against Yersinia-mediated cell death. Similarly, apoptosis provoked by treatment of macrophages with the TLR4 agonist LPS in the presence of a proteasome inhibitor was inhibited in TRIF-defective, but not in MyD88-negative, cells. The transfection of macrophages with TRIF furthermore potently promoted macrophage apoptosis, a process that involved activation of a Fas-associated death domain- and caspase-8-dependent apoptotic pathway. These data indicate a crucial function of TRIF as proapoptotic signal transducer in bacteria-infected murine macrophages, an activity that is not prominent for MyD88. The ability to elicit TRIF-dependent apoptosis was not restricted to TLR4 activation, but was also demonstrated for TLR3 agonists. Together, these results argue for a specific proapoptotic activity of TRIF as part of the host innate immune response to bacterial or viral infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322195     DOI: 10.4049/jimmunol.173.5.3320

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

Review 1.  Deciphering the complexity of Toll-like receptor signaling.

Authors:  Renato Ostuni; Ivan Zanoni; Francesca Granucci
Journal:  Cell Mol Life Sci       Date:  2010-07-31       Impact factor: 9.261

Review 2.  Autophagy in innate and adaptive immunity.

Authors:  Yi Xu; N Tony Eissa
Journal:  Proc Am Thorac Soc       Date:  2010-02

3.  MyD88 deficiency leads to decreased NK cell gamma interferon production and T cell recruitment during Chlamydia muridarum genital tract infection, but a predominant Th1 response and enhanced monocytic inflammation are associated with infection resolution.

Authors:  Uma M Nagarajan; James Sikes; Daniel Prantner; Charles W Andrews; Lauren Frazer; Anna Goodwin; Jessica N Snowden; Toni Darville
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

Review 4.  Apoptosis in infectious disease: how bacteria interfere with the apoptotic apparatus.

Authors:  Georg Häcker; Susanne Kirschnek; Silke F Fischer
Journal:  Med Microbiol Immunol       Date:  2005-08-06       Impact factor: 3.402

5.  Absence of Toll-like receptor 4 signaling results in delayed Yersinia enterocolitica YopP-induced cell death of dendritic cells.

Authors:  Sabine Gröbner; Sebastian Schulz; Irena Soldanova; Dani S J Gunst; Michaela Waibel; Sebastian Wesselborg; Stefan Borgmann; Ingo B Autenrieth
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

Review 6.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

7.  A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity.

Authors:  Sky W Brubaker; Anna E Gauthier; Eric W Mills; Nicholas T Ingolia; Jonathan C Kagan
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

Review 8.  Disifin (sodium tosylchloramide) and Toll-like receptors (TLRs): evolving importance in health and diseases.

Authors:  Okom Nkili F C Ofodile
Journal:  J Ind Microbiol Biotechnol       Date:  2007-09-05       Impact factor: 3.346

Review 9.  Sensing of viral infection and activation of innate immunity by toll-like receptor 3.

Authors:  Elisabeth Vercammen; Jens Staal; Rudi Beyaert
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 10.  Toll-like receptors in control of immunological autophagy.

Authors:  M A Delgado; V Deretic
Journal:  Cell Death Differ       Date:  2009-05-15       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.